Published: 5 Jun 2026 | Last data refresh: 5 Jun 2026 (UOB FY2025 Annual Report; 1Q2026 results released 7 May 2026) | SGX: U11
At ~S$37.30 (around mid-May 2026), UOB trades at 1.25x book value — a discount to both OCBC (1.32x) and DBS (around 2.0x), and the lowest absolute price-to-book ratio of Singapore’s three major banks. A dividend discount model anchored to consensus FY2026 ordinary DPS of S$1.72 yields a fair value of S$41.95 on a conservative Gordon Growth basis, or S$45.80 on a two-stage model — both suggesting the current price is undemanding. The Justified P/B framework tells a more provocative story: at a normalised sustainable ROE of 10.6%, UOB’s book value supports a fair value of S$58.85. That is a separate analytical lens, not a price target, and the S$17 gap between it and the Gordon Growth answer requires an explanation — one that sits at the core of this piece. Most striking is what the Reverse P/B implies: that the market is pricing UOB as though its long-run return on equity (ROE — annual net profit as a percentage of ordinary shareholders’ equity) will settle at 7.6%, a level the bank has not seen in at least a decade, and roughly 400 basis points below its five-year average of 11.5%. Either the market is anticipating structural deterioration the numbers do not yet show, or UOB is the most mispriced of Singapore’s big three. This piece works through the math and lays out what would have to be true for each conclusion to hold.
Why This Matters Now
UOB reported 1Q2026 results on 7 May 2026 — net profit of S$1.4 billion, up 2% quarter-on-quarter and down 4% year-on-year. The YoY decline reflects the elevated 1Q2025 comparison base, not operational deterioration. More substantively, this is the first full quarter following UOB’s completion of the Citi consumer banking integration across all four ASEAN-4 markets. The integration is done; what matters now is whether the enlarged customer base of approximately 5 million new clients translates into earnings.
The S$2 billion share buyback — part of the S$3 billion capital return programme announced in February 2025 — is in active execution, with approximately one-third completed by end-2025 and roughly S$1.33 billion remaining through 2026–2027. Buybacks executed below intrinsic value are mechanically accretive to book value per share and ROE for remaining shareholders, a tailwind the current price does not obviously reflect.
What the Numbers Actually Show
FY2025 reported net profit was S$4.68 billion, down 22.5% from S$6.05 billion in FY2024 — almost entirely explained by a S$615 million pre-emptive general provision (GP) in 3Q2025, which management characterised as a macro buffer rather than a response to actual loan deterioration. Adding back the after-tax impact of S$510 million, normalised net profit is approximately S$5.19 billion, implying a normalised ROE of 10.6% versus the 9.6% reported. The 1Q2026 data supports this reading: annualised ROE of 11.5%, credit costs of 26 basis points within guidance, and the NPL ratio (non-performing loan ratio: proportion of loans 90+ days overdue) stable at 1.5%.
Ordinary DPS fell from S$1.80 in FY2024 to S$1.56 in FY2025, a cut of 13.3%. UOB’s payout policy is approximately 50% of reported earnings; when reported earnings declined on the GP charge, dividends followed mechanically. The S$0.50 special dividend also paid during 2025 — a non-recurring 90th anniversary distribution from the S$3 billion capital return programme — should not be added to this figure. The relevant question is whether the ordinary dividend recovers as normalised earnings do, not whether the special was large.
| Metric | FY2023 | FY2024 | FY2025 | 1Q2026 |
|---|---|---|---|---|
| Total Income (S$B) | 13.93 | 14.29 | 13.81 | 3.42 |
| Net Profit Reported (S$B) | 5.71 | 6.05 | 4.68 | 1.44 |
| Ordinary DPS (S$) | 1.70 | 1.80 | 1.56 | — |
| Reported ROE | 13.4% | 13.3% | 9.6% | 11.5% (ann.) |
| NIM | 2.09% | 2.03% | 1.89% | 1.82% |
| NPL Ratio | 1.5% | 1.5% | 1.5% | 1.5% |
| CET1 (transitional) | 13.4% | 15.5% | 15.1% | 15.3% |
Source: UOB Annual Report 2025; UOB 1Q2026 Performance Highlights, 7 May 2026.
NIM (net interest margin: the spread between what the bank earns on loans and investments versus what it pays on deposits, as a percentage of interest-bearing assets) has compressed steadily from 2.09% in FY2023 to 1.82% in 1Q2026. Management guides 1.75–1.80% for the full year — modest further compression, or none if the rate environment cooperates.
The ASEAN Bet Is Already in the Numbers — or Is It?
UOB’s five-year ROE series spans a complete interest rate cycle, from post-COVID recovery through peak rates and back:
| Year | Reported ROE |
|---|---|
| FY2021 | 10.2% |
| FY2022 | 11.2% |
| FY2023 | 13.4% |
| FY2024 | 13.3% |
| FY2025 | 9.6% |
| Five-year average | 11.5% |
Source: UOB Annual Report 2025.
The 11.5% average covers the full cycle. The current normalised ROE of 10.6% is modestly below it — reflecting NIM compression and a more cautious credit environment — but not dramatically so. The Reverse P/B implied ROE of 7.6% is a different matter entirely.
The strategic backdrop is the completed Citi consumer integration across Malaysia, Thailand, Indonesia, and Vietnam — approximately 5 million new customers now in the run-rate. Early 1Q2026 signals are positive: retail CASA up 10% YoY, card billings up 7%, wealth income up 6%, trade loans up 19%. The integration is done; the question is whether 1.25x P/B reflects what it has added.
Where UOB structurally trails peers: normalised ROE of 10.6% sits between OCBC’s 12.6% and DBS’s approximately 17%; wealth AUM of S$198 billion compares to OCBC’s S$343 billion; NIM of 1.82% is broadly in line with OCBC but below DBS. The ROE gap versus peers is real and is the primary explanation for the P/B discount. What the valuation section tests is whether the size of that discount is proportionate to the gap — or whether it prices in deterioration the numbers do not yet show.
Returning Capital While the Discount Persists
UOB’s CET1 (Common Equity Tier 1) stood at 15.3% as at 31 March 2026 — comfortably above operating requirements and providing the headroom for the capital return programme without balance sheet stress.
The S$3 billion programme breaks into two parts. The S$0.50 special dividend per share was paid in two tranches during 2025 to mark UOB’s 90th anniversary; it was a non-recurring one-off distribution and should not be assumed to recur. The S$2 billion share buyback is ongoing — approximately one-third done by end-2025 (roughly S$667 million executed), leaving approximately S$1.33 billion still ahead through 2026–2027.
Buying back shares at 1.25x book is not value-accretive on a P/B basis in isolation. But because the buyback is funded from surplus capital that would otherwise earn only deposit rates, each cancelled share reduces the share count without proportionally reducing earning power — lifting EPS and book value per share for remaining holders. At S$37.30, consensus FY2026 ordinary DPS of S$1.72 implies a forward yield of approximately 4.6%; the buyback is the more interesting part of the capital return story.
Unpacking the 1.25x P/B Discount
Cost of equity
CAPM: Rf = 2.10% (MAS SGS 10-year, 15 May 2026), equity risk premium = 5.0%, beta = 0.90 (UOB STI-relative 5-year; between the 0.85 used for DBS and the 0.95 used for OCBC in this series, reflecting UOB’s STI correlation). Ke = 6.60%.
Dividend discount model
A Two-Stage DDM — S$1.72 starting dividend, 5% growth for five years, 2.5% terminal — gives S$45.80 (+22.8%). The simpler Gordon Growth perpetuity at the same terminal rate gives the conservative anchor: S$41.95 (+12.5%). This requires only that ordinary dividends grow at Singapore’s long-run inflation rate — no heroic assumptions about reinvestment returns. Stress-testing the terminal rate down to 2.0% produces S$37.39, essentially at parity with today’s price. Even maximum pessimism on dividend growth barely justifies the current price.
Justified P/B and the S$17 gap
The Justified P/B formula — (ROE − g) / (Ke − g) — applied to NAV per share of S$29.79 gives S$51.59 using FY2025 reported ROE (9.6%), S$58.85 using normalised ROE (10.6%), and S$65.39 using the 1Q2026 annualised ROE (11.5%). Even the bear case, anchored to the GP-depressed reported ROE, sits well above the current price.
S$58.85 is what UOB would be worth if 10.6% normalised ROE is genuinely sustainable in perpetuity. It is not the primary fair value anchor and not a price target — but the S$17 gap between it and S$41.95 needs explaining, because it is the intellectual core of comparing these two frameworks.
The DDM values only the dividend stream. At a 50% payout, UOB retains half its earnings; the DDM treats those retained earnings as worth exactly book value, implicitly assuming they earn only Ke (6.60%) on reinvestment. The Justified P/B makes an explicit different assumption: retained earnings reinvest at 10.6% ROE. Because 10.6% > 6.60%, each retained dollar creates more than a dollar of value. The S$17 gap is the NPV of that reinvestment spread — real if ROE stays above Ke, zero if it does not. I anchor to S$41.95 because it requires no such belief.
Reverse P/B: what the market is actually pricing
Implied ROE = Current P/B × (Ke − g) + g
At P/B = 1.252x, Ke = 6.60%, g = 2.5%: implied long-run sustainable ROE = 7.63%.
The 7.63% implied ROE sits roughly 400 basis points below the five-year average of 11.5% — and below every single year in the series, including the provisioning-heavy FY2025 trough of 9.6%. For the current price to be correct, UOB would need to structurally de-rate to a level of profitability it has not operated at in recent memory. To justify S$37.30 in the Justified P/B framework requires a sustainable ROE of approximately 8% at Ke 6.60% — well below normalised 10.6%, and not a minor rounding difference. The gap between implied ROE (7.63%) and current normalised ROE (10.6%) is the central question this article is asking the reader to form a view on.
What Would Have to Be True for the Bear Case to Win
Risk 1 — Greater China credit deterioration. Greater China NPL has risen from 2.7% (March 2025) to 3.5% (March 2026) on approximately S$49 billion of customer loans (14% of the Group). NPA coverage for this portfolio is 57% — versus the group-wide 100%. A rise above 4.5% with coverage held flat could generate specific provision charges approaching S$500 million, materially cutting FY2026 earnings and calling the normalised ROE assumption into question.
What would change my view: Greater China NPL above 5% for two consecutive quarters without meaningful coverage improvement.
Risk 2 — NIM compresses below guidance. Full-year guidance is 1.75–1.80%; 1Q2026 printed at 1.82%. A 10bps undershoot on approximately S$517 billion of interest-bearing assets reduces net interest income by roughly S$430 million post-tax, lowering forward DPS by approximately S$0.12 at the 50% payout ratio and pulling the Gordon Growth base fair value from S$41.95 down to approximately S$38.10.
What would change my view: 2Q2026 NIM printing below 1.75%.
Risk 3 — Buyback suspended. The S$2 billion programme is not contractually committed to a fixed pace. If credit conditions deteriorate, management could redirect surplus capital to provisioning. A suspension would remove the per-share accretion tailwind and signal management concern about balance sheet quality.
What would change my view: A public announcement of buyback suspension citing credit quality concerns.
Risk 4 — Structural ROE compression below 9%. The S$41.95 floor holds as long as ordinary DPS recovers toward S$1.72 and grows at 2.5% long-run, which requires sustained normalised ROE above approximately 9%. Below that level, the dividend recovery thesis breaks and the current price offers little margin of safety.
What would change my view: FY2026 normalised ROE (excluding deliberate GP charges) below 9%.
Closing Thought
At ~S$37.30 mid-May 2026, UOB is priced for a sustainable ROE of 7.6% — a level the bank has not delivered in any of the past five years, and roughly 400 basis points below its five-year average. The conservative fair value of S$41.95 requires only that ordinary dividends grow at Singapore’s long-run inflation rate; even maximum pessimism on dividend growth barely justifies today’s price. The question a reader needs to resolve is whether Greater China credit risk and structurally lower NIM represent a genuine earnings floor that invalidates the 10.6% normalised ROE assumption — or whether the market is being overly conservative about a well-capitalised bank with a completed ASEAN integration behind it and approximately S$1.33 billion of buyback still ahead. My model, my assumptions, my holding. You should run your own numbers.
Disclosure: At time of writing, the author holds a long position in UOB Group (SGX: U11), comprising approximately 100 shares.
Disclaimer: This article reflects the author’s personal analysis and opinions, written in a strictly personal capacity. It is not financial advice and does not take into account any individual reader’s financial situation, investment objectives, or risk tolerance. Information is sourced from publicly available filings as of the date noted but accuracy cannot be guaranteed. The author may hold positions in securities discussed (see disclosure above). Readers should conduct their own research and consider consulting a licensed financial adviser before making any investment decisions. The author is not a licensed financial adviser under the Financial Advisers Act of Singapore.
An ordinary man with extraordinary inspiration